Blood could tell how long brain tumor patients have and how well their treatment is working
The Holy Grail in the brain tumor field, according to Mayfield Clinic neurosurgeonDr. Ron Warnick, would be a non-invasive test allowing personalized therapy, a way to reliably distinguish if the tumor has grown back, and the ability to make a very specific prognosis. This blood test is still in the research stage. WVXU's Ann Thompson, in "Focus on Technology," reports how it would work and the hope that it carries.